International Journal of Sexually Transmitted Diseases

Submit Manuscript

International Journal of Sexually Transmitted Diseases

Reviewer guidelines

What the International Journal of Sexually Transmitted Diseases asks of a peer reviewer: when to accept, what to assess in an STI manuscript, how to write comments an author can act on, and what confidentiality requires.

Review model Single-blind by default; double-blind review is available on request. Reviewers Normally at least two Confidentiality Manuscripts and nonpublic material Recommendation Advisory; the editor decides

01 · The invitation

Accepting or declining

The journal states its review model as it operates. Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts, and your assessment is one of them.

Accept an invitation only where you can assess the manuscript on its methods as well as its subject, and where you can return the review by the date agreed. Declining promptly is more useful to the authors than accepting and delaying, and suggesting a colleague who is better placed is more useful still.

  • Expertise. You do not need to cover every aspect of a manuscript. Review what you can assess and say plainly which parts fall outside your competence, so the editor can seek that assessment elsewhere.
  • Competing interests. Decline where you have a personal relationship with an author, a recent collaboration, competing work in progress, a financial interest in the outcome, or a shared institution. Where you are uncertain, describe the situation to the handling editor and let them decide.
  • Time. Agree a date at the point of acceptance, and tell the editor as soon as you know it will slip so the manuscript can be reassigned.
  • Delegation. Do not pass a manuscript to a colleague or a trainee without the editor's agreement. Where a co-review is agreed, name the co-reviewer so their contribution is on the record.

02 · The assessment

What to assess

The question
Whether the study addresses a question that is open, and whether the design can answer it.
Methods
Whether the design, setting, recruitment, exposures, outcome definitions and procedures are described in enough detail for a qualified investigator to repeat the work, and whether the sources of bias are identified and handled.
Statistics
Whether the analysis matches the design, whether the sample size supports the claims, how missing data were handled, and whether effect sizes and confidence intervals are reported rather than threshold statements.
Results
Whether the numbers in the text, tables and figures agree, whether participant flow is accounted for, and whether every result presented is one the methods can produce.
Interpretation
Whether the conclusions follow from the data, whether limitations are stated and their effect acknowledged, and whether the discussion engages the studies that disagree.
Originality and relevance
What the work adds to the existing evidence on sexually transmitted infection, and whether it falls within the journal's scope.
Reporting quality
Whether the manuscript follows the guideline for its design — CONSORT, STROBE, PRISMA, STARD or ARRIVE — and whether the checklist matches the text.
Ethics
Whether the ethics statement documents approval or an applicable exemption or waiver, consent requirements are addressed, and trial registration and data availability are reported where applicable.

03 · This field

What an STI manuscript needs to be read for

Assess each manuscript against the requirements of its study design. Qualitative research should explain sampling, reflexivity and analysis; implementation research should address context, feasibility, acceptability or uptake as appropriate. Do not require numerical effect sizes or infection outcomes when they do not answer the research question.

Diagnostics. Is the assay named with its platform and version, and is the reference standard appropriate rather than merely available? Sensitivity and specificity belong with confidence intervals; predictive values depend on prevalence, so the tested population's prevalence has to be stated for them to mean anything. Self-collected and clinician-collected specimens are not interchangeable without evidence, and extragenital site performance is not inferable from genital site performance.

Antimicrobial resistance. Is the susceptibility testing method named, with the breakpoints applied and their source and version? Are resistance genotypes distinguished from phenotypes, and is a treatment failure distinguished from reinfection?

Epidemiology. Is the denominator the population at risk, or the population tested? Testing-driven artifacts are the commonest explanation for a trend in STI surveillance data, and a manuscript that reports rising incidence without addressing changes in testing volume has not yet made its case.

Clinical and preventive studies. Is adherence measured or assumed? Are partner outcomes reported where the intervention acts on transmission? Is the follow-up long enough for the outcome claimed?

Privacy and interpretation

Check that identification risk is minimized, including risks arising from combinations of indirect details. A small cell count beside a named site, a narrow date range and a demographic descriptor can identify someone even where no direct identifier appears.

Check the language of interpretation. Populations are described by what is true of them, in the terminology used in the authoritative clinical and public-health literature. Infection is not treated as a property of an identity, and risk is described where it is measured rather than attributed. Raise overreach from sensitive population data as a scientific point about what the data support.

04 · The review

Writing the review

  • Open with what the study is and what it adds, in two or three sentences. It shows the authors and the editor what you took the work to be claiming.
  • Separate the essential from the optional. Number the points that must be addressed for the findings to hold, then list the improvements you would suggest. An undifferentiated list of forty comments tells the editor nothing about severity.
  • Locate every point. Give the page, line or table so the authors can find it.
  • Say what would resolve it. "The analysis does not account for X" is a comment; "adjusting for X, or explaining why it cannot be, would resolve this" is a review.
  • Review the work, not the authors. Comments are professional and specific; the authors read them.
  • Acknowledge the strengths. An editor weighing conflicting recommendations needs to know what you thought was sound as well as what was not.
  • Use the confidential comments to the editor for anything the authors should not see: a suspicion of misconduct, a competing interest you discovered while reading, or the limits of your own assessment.

Recommend accept, minor revision, major revision or reject, and treat the recommendation as advice. The decision is the editor's: editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal.

05 · Confidentiality and conduct

Confidentiality, AI use and files

Confidentiality
A manuscript under review is confidential. Publication does not authorize disclosure of unpublished drafts, confidential reviews, correspondence or participant information. Do not share it, discuss its content, or use unpublished information from it in your own work or to inform a decision of your own.
Double-blind manuscripts
For double-blind manuscripts, reviewers must not attempt to identify the authors.
AI use
Reviewers must obtain journal permission before using AI to assist with a review. Any permitted use must be disclosed, and confidential manuscript content must not be uploaded where confidentiality cannot be assured.
Files
After submitting the review, reviewers should securely delete downloaded manuscript files and must not retain or use unpublished material.
Suspected misconduct
Report suspected fabrication, falsification, plagiarism, undisclosed duplicate publication or image manipulation to the handling editor in the confidential comments, with the evidence. Do not contact the authors.
Independence
Reviewing confers no advantage in the review of a reviewer's own submissions, and no fee, service, membership or role affects any editorial decision.

06 · Joining

Reviewing for IJSTD

Researchers and clinicians working across sexually transmitted infection are invited to review. Email the editorial office with a CV, subject areas, methodological expertise, relevant publications and ORCID iD where available. Invitations follow an assessment of expertise and independence.

07 · Routes

Where to go next

International Journal of Sexually Transmitted Diseases (IJSTD) · ISSN 2994-6743 · Crossref DOI prefix 10.14302 · published open access by Open Access Pub under CC BY 4.0. Editorial decisions are independent of any fee, service, membership or role.

Menu